NEJM This Week — February 8, 2024

NEJM This Week

Featuring articles on a phase 3 trial of resmetirom in NASH with liver fibrosis, an interleukin-23–receptor antagonist for plaque psoriasis, the neurovascular complications of F. solani meningitis, and on ocular gene therapy; a review article on coccidioidomycosis and histoplasmosis; a case report of a man with fever and headache after international travel; Medicine and Society articles on a physician attack on the FDA and on being well while doing well; and Perspective articles on the risks of normalizing parental vaccine hesitancy, on advanced HIV as a neglected disease, on the challenge of common chronic diseases, and on “the saddest waste”.